Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.
about
Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish communityScreening for Anal Cancer in WomenAutologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.A national study of the complications of lupus in pregnancy.Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximabClinical and immunological characteristics in 552 systemic lupus erythematosus patients in a southern province of China.Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.Understanding the epidemiology and progression of systemic lupus erythematosusPediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusMucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literatureEstrogen in cardiovascular disease during systemic lupus erythematosusAntimalarials may influence the risk of malignancy in systemic lupus erythematosus.Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality.Acute myeloid leukemia developing in patients with autoimmune diseases.Current issues in pediatric lupus nephritis: role of revised histopathological classification.Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4Malignancies in systemic lupus erythematosusResource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population.Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years.Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea.Why are kids with lupus at an increased risk of cardiovascular disease?Mortality in Systemic Lupus Erythematosus: an Updated Review.The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012.Systemic lupus erythematosus and malignancies risk.Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis.B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality.Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.The causes of death in Korean patients with systemic lupus erythematosus over 11 years.Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population.
P2860
Q22299249-AB457A23-9BFA-4C25-BAD7-DCDEEA799127Q28085226-6A73C79F-0EE1-4824-8336-F1251011224FQ30582614-3B69665A-57EF-4FA5-9ABF-33E7E51729D7Q33363684-0C84140C-4B3E-4DCA-BAC3-E50B41B0166AQ33379485-9842C9CB-7EB6-40FC-B7E5-D72828519683Q33420201-3F30C323-B410-48EF-8A66-B7D685AD3C6BQ33421916-C86C35F7-3758-4E75-B4A5-03C6B1CFF22BQ33423725-2E2E4CF7-B912-46C6-8760-30BA1375EC58Q33621131-467A7C8C-6850-40D9-9BDA-5D9F0C68AC8CQ33723511-CD0DC211-2C73-4466-90EF-0A38B0A28861Q33766242-B7822504-4571-4300-9F1D-7F1D770B3717Q33937936-D44BE42F-771B-401C-82B4-9D285314F0C1Q34087831-02BEFAE7-9553-462D-B8A1-76F32B366CC9Q34937950-9B07664B-A6F2-472E-9385-BEE77CD32AC6Q35162962-2E6413F3-3A56-4515-A9FC-8A236A0FEAB4Q35953395-1F11F7E9-9553-423E-88B4-90E90F445994Q35954573-AD3942CA-0130-4847-90FD-3BB5D79E5011Q36006358-4100F615-6D08-4E38-B932-3F9F386D4FE8Q36908996-4211318E-9697-4987-AE3F-5F554E4A420CQ37127464-A9BAB599-6079-4143-B818-689A7BC354B3Q37146254-FE6F077D-321E-407F-894F-9DBE2D1B1B12Q37433350-543F6F78-9138-446C-827B-C77F533F4584Q38076062-A303C90D-AA0C-48FF-ADFF-47630FFD83BCQ38138918-D08C638E-D2C0-49F5-9D34-74B95518B8E2Q38471960-298F8624-9892-48A4-A723-C1D372265D74Q38591752-D87CB470-64CE-4016-A2D8-D88FB7F2EA78Q38777770-DBBD6800-87D6-44A6-8CB9-84B4486697B1Q40047382-845A2400-703D-4BBA-9184-AF48280DB806Q40126330-3263C3B2-EA04-4C46-AC18-4EC42E2995C5Q40949132-79E667AD-AAE3-460F-AFE5-F748BF27E22CQ41441163-DB519BBF-AF5C-4241-A048-86671DD238AEQ41698087-2BEEB308-9A21-4297-9282-2E7A8DF51567Q42211485-9D27A4DE-2BEC-4CAD-9FFB-42BDE671FD49Q42669194-A568C75F-4B26-4D44-BB4A-F481EC8ECBC4Q44672345-B4CCD84F-543F-402B-B552-90E3825B250AQ44800972-96E200FE-5AF2-40DE-8EB8-10EEBC79CE38Q45349765-52241925-C329-4FDA-B7CC-F49BE8AAD8DBQ45812853-757B8C7E-6B65-4804-AC9A-646E287F80BFQ46216656-9380AFC0-AC3A-4F9D-93BF-551916C6EA9FQ46603420-2866850C-56FA-4977-95E2-12C57F8D86CA
P2860
Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@ast
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@en
type
label
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@ast
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@en
prefLabel
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@ast
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@en
P2093
P2860
P356
P1476
Outcome of a cohort of 300 pat ...... d clinic for over two decades.
@en
P2093
P2860
P304
P356
10.1136/ARD.61.5.409
P407
P577
2002-05-01T00:00:00Z